Historical Stock Price
PCYC historical stock prices picture
PCYC (PCYC) has the following price history information. Looking back at PCYC historical stock prices for the last five trading days, on May 19, 2015, PCYC opened at $258.05, traded as high as $259.06 and as low as $258.05, and closed at $258.95. Trading volume was a total of 743.60K shares. On May 20, 2015, PCYC opened at $259.16, traded as high as $259.20 and as low as $258.06, and closed at $258.73. Trading volume was a total of 328.90K shares. On May 21, 2015, PCYC opened at $259.00, traded as high as $260.25 and as low as $258.61, and closed at $259.55. Trading volume was a total of 1.92M shares. On May 22, 2015, PCYC opened at $260.76, traded as high as $261.68 and as low as $260.76, and closed at $261.25. Trading volume was a total of 1.95M shares. On May 26, 2015, PCYC opened at $261.25, traded as high as $261.25 and as low as $261.25, and closed at $261.25. Trading volume was a total of 0 shares.

PCYC Historical Stock Prices By Date:

PCYC historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into PCYC shares, starting with a $10,000 purchase of PCYC, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/01/2014
End date: 05/26/2015
Start price/share: $107.42
End price/share: $261.25
Dividends collected/share: $0.00
Total return: 143.20%
Average Annual Total Return: 116.48%
Starting investment: $10,000.00
Ending investment: $24,319.81
Years: 1.15
Date Open High Low Close Volume
05/19/2015 $258.05 $259.06 $258.05 $258.95 743.60K
05/20/2015 $259.16 $259.20 $258.06 $258.73 328.90K
05/21/2015 $259.00 $260.25 $258.61 $259.55 1.92M
05/22/2015 $260.76 $261.68 $260.76 $261.25 1.95M
05/26/2015 $261.25 $261.25 $261.25 $261.25 0
Pharmacyclics is a biopharmaceutical company that designs, develops and commercializes therapies with a focus on product candidates that are small-molecule drugs for the treatment of cancer and immune-mediated diseases. Co.'s IMBRUVICA™ product has been developed for mantle cell lymphoma and chronic lymphocytic leukemia patients, who in each case have received at least one prior therapy. Co. also has three other product candidates in clinical development, including a Bruton's tyrosine kinase inhibitor targeting anti-inflammatory and autoimmune indications, an inhibitor of Factor VIIa (PCI-27483), and a histone deacetylase inhibitor targeting in solid tumors and hematological malignancies.
Date Close
05/19/2015$258.95
05/20/2015$258.73
05/21/2015$259.55
05/22/2015$261.25
05/26/2015$261.25
PCYC is categorized under the Healthcare sector; below are some other companies in the same sector:

PDCO Historical Stock Prices
PDEX Historical Stock Prices
PDII Historical Stock Prices
PEN Historical Stock Prices
PETX Historical Stock Prices
PFE Historical Stock Prices
PFNX Historical Stock Prices
PGNX Historical Stock Prices
PHMD Historical Stock Prices
PIP Historical Stock Prices

Email EnvelopeFree PCYC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


PCYC Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.